Clinical audit of the high risk medications use in pediatric and neonatal intensive care units - Pre and post intervention

Anjali Goyal; Nazima Mirza; Rhythm; Monica Gupta; Bharat Gajjar

doi:10.5455/njppp.2021.11.10271202016102020

2024, Vol: 14, Issue: 12

14 / 12Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form

« Previous Article

Original Research
Online Published: 26 Oct 2020

Natl J Physiol Pharm Pharmacol. 2020; 10(12): 1091-1094

doi: 10.5455/njppp.2021.11.10271202016102020

Clinical audit of the high risk medications use in pediatric and neonatal intensive care units - Pre and post intervention

Anjali Goyal, Nazima Mirza, Rhythm, Monica Gupta, Bharat Gajjar.

Cited By:1

Abstract
Background: Clinical audit is a quality improvement process that seeks to improve patient care and outcomes through systematic review of care against explicit criterion and the implementation of change. Prescribing of high-risk medications (HRMs) in pediatrics age group can pose a unique set of risk of medication errors, because of the need for individual dosage calculations.

Aim and Objective: The aim of the study was to evaluate the compliance to institutional guidelines while prescribing HRMs in the Neonatal Intensive Care Unit (NICU) and Pediatric Intensive Care Unit (PICU).

Materials and Methods: This was a record based retrospective observational study carried out in the NICU and PICU of Shree Krishna Hospital, Karamsad. The standard was evaluated against the four criteria mentioned in the institutional guidelines for the use of HRMs. These criteria were whether HRMs were (1) highlighted with red color in prescription, (2) prescribed in adequate dose, (3) verified by two nurses or doctors before administration, and (4) monitored after administration to the patient.

Results: A total of 36 and 37 case files were audited during the first and follow-up audit, respectively. The targets of 100% were achieved for criterion 2, 3 and 4 in the first audit as well as follow-up audit. The target of criterion 1 improved from 0% in the first audit to 46.66% in a follow-up audit.

Conclusion: Regular follow-up audits of HRM use are required to prevent medication errors and adverse drug reactions.

Key words: Clinical Audit; High-risk Medications; Medication errors

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Anjali Goyal Articles by Nazima Mirza Articles by Rhythm Articles by Monica Gupta Articles by Bharat Gajjar
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Goyal A, Mirza N, Rhythm , Gupta M, Gajjar B. Clinical audit of the high risk medications use in pediatric and neonatal intensive care units - Pre and post intervention. Natl J Physiol Pharm Pharmacol. 2020; 10(12): 1091-1094. doi:10.5455/njppp.2021.11.10271202016102020

Web Style

Goyal A, Mirza N, Rhythm , Gupta M, Gajjar B. Clinical audit of the high risk medications use in pediatric and neonatal intensive care units - Pre and post intervention. https://www.njppp.com/?mno=9732 [Access: January 18, 2025]. doi:10.5455/njppp.2021.11.10271202016102020

AMA (American Medical Association) Style

Goyal A, Mirza N, Rhythm , Gupta M, Gajjar B. Clinical audit of the high risk medications use in pediatric and neonatal intensive care units - Pre and post intervention. Natl J Physiol Pharm Pharmacol. 2020; 10(12): 1091-1094. doi:10.5455/njppp.2021.11.10271202016102020

Vancouver/ICMJE Style

Goyal A, Mirza N, Rhythm , Gupta M, Gajjar B. Clinical audit of the high risk medications use in pediatric and neonatal intensive care units - Pre and post intervention. Natl J Physiol Pharm Pharmacol. (2020), [cited January 18, 2025]; 10(12): 1091-1094. doi:10.5455/njppp.2021.11.10271202016102020

Harvard Style

Goyal, A., Mirza, . N., Rhythm, ., Gupta, . M. & Gajjar, . B. (2020) Clinical audit of the high risk medications use in pediatric and neonatal intensive care units - Pre and post intervention. Natl J Physiol Pharm Pharmacol, 10 (12), 1091-1094. doi:10.5455/njppp.2021.11.10271202016102020

Turabian Style

Goyal, Anjali, Nazima Mirza, Rhythm, Monica Gupta, and Bharat Gajjar. 2020. Clinical audit of the high risk medications use in pediatric and neonatal intensive care units - Pre and post intervention. National Journal of Physiology, Pharmacy and Pharmacology, 10 (12), 1091-1094. doi:10.5455/njppp.2021.11.10271202016102020

Chicago Style

Goyal, Anjali, Nazima Mirza, Rhythm, Monica Gupta, and Bharat Gajjar. "Clinical audit of the high risk medications use in pediatric and neonatal intensive care units - Pre and post intervention." National Journal of Physiology, Pharmacy and Pharmacology 10 (2020), 1091-1094. doi:10.5455/njppp.2021.11.10271202016102020

MLA (The Modern Language Association) Style

Goyal, Anjali, Nazima Mirza, Rhythm, Monica Gupta, and Bharat Gajjar. "Clinical audit of the high risk medications use in pediatric and neonatal intensive care units - Pre and post intervention." National Journal of Physiology, Pharmacy and Pharmacology 10.12 (2020), 1091-1094. Print. doi:10.5455/njppp.2021.11.10271202016102020

APA (American Psychological Association) Style

Goyal, A., Mirza, . N., Rhythm, ., Gupta, . M. & Gajjar, . B. (2020) Clinical audit of the high risk medications use in pediatric and neonatal intensive care units - Pre and post intervention. National Journal of Physiology, Pharmacy and Pharmacology, 10 (12), 1091-1094. doi:10.5455/njppp.2021.11.10271202016102020

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Digital Archiving & Preservation Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article